BUPivacaine liposomal
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications: 
Pronunciation: 
byoo-pi-vi-kane lye-poe-some
 To hear audio pronunciation of this topic, purchase a subscription or log in.
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Exparel
Ther. Class.
anesthetics (topical/local)
Pharm. Class.
amides
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "BUPivacaine Liposomal." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110967/all/BUPivacaine_liposomal. 
Vallerand AHA, Sanoski CAC,  . BUPivacaine liposomal. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110967/all/BUPivacaine_liposomal. Accessed October 30, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). BUPivacaine liposomal. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110967/all/BUPivacaine_liposomal
Vallerand AHA, Sanoski CAC,  . BUPivacaine Liposomal [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 30]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110967/all/BUPivacaine_liposomal.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  BUPivacaine liposomal
ID  -  110967
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110967/all/BUPivacaine_liposomal
PB  -  F.A. Davis Company
ET  -  19
DB  -  Pediatrics Central
DP  -  Unbound Medicine
ER  -  

 Davis's Drug Guide
Davis's Drug Guide

